Effects of Bafilomycin A1: An inhibitor of vacuolar H (+)‐ATPases on endocytosis and apoptosis in RAW cells and RAW cell‐derived osteoclasts

Bafilomycin A1, a specific inhibitor of V‐ATPases, is a potent inhibitor of bone resorption, but the underlying mechanisms of its action remain unclear. In this study, we investigated the effect of Bafilomycin A1 on endocytosis and apoptosis in RAW cells and RAW cell‐derived osteoclasts. Quantitative analysis by flow cytometry showed that Bafilomycin A1 increased total transferrin levels when RAW cells were exposed to labeled transferrin and decreased the total uptake of Dextran‐rhodamine B, both in a dose‐ and time‐dependent fashion, indicating that Bafilomycin influences receptor‐mediated and fluid phase endocytosis in these cells. Furthermore, Bafilomycin A1 induced apoptosis of RAW cells in a dose dependent manner as evidenced by Annexin V flow cytometry. The action of Bafilomycin A1 on endocytotic events appeared to be more sensitive and occurred earlier than on its apoptosis inducing effects, suggesting that interrupting of endocytosis might be an early sign of Bafilomycin‐mediated osteoclast inhibition. Semi‐quantitative RT‐PCR analysis showed that the gene transcripts of putative Bafilomycin A1 binding subunit, V‐ATPase‐subunit a3, were expressed in the preosteoclastic RAW cell line, and up‐regulated during RANKL‐induced osteoclastogenesis. Osteoclasts treated with Bafilomycin A1 exhibited apoptosis as well as altered cellular localization of Transferrin Alexa 647. Given that endocytosis and apoptosis are important processes during osteoclastic bone resorption, the potent effect of Bafilomycin A1 on endocytosis and apoptosis of osteoclasts and their precursor cells may in part account for Bafilomycin A1 inhibited bone resorption. J. Cell. Biochem. 88: 1256–1264, 2003. © 2003 Wiley‐Liss, Inc.

[1]  C. Parini,et al.  Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase. , 2001, Farmaco.

[2]  S. Wysocki,et al.  Cloning, Sequencing, and Functional Characterization of the Rat Homologue of Receptor Activator of NF‐κB Ligand , 2000 .

[3]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[4]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[5]  T. Skerry,et al.  Tetracyclines induce apoptosis in osteoclasts. , 2000, Bone.

[6]  T. Oka,et al.  Three Subunit a Isoforms of Mouse Vacuolar H+-ATPase , 2000, The Journal of Biological Chemistry.

[7]  T. Nishi,et al.  Molecular Cloning and Expression of Three Isoforms of the 100-kDa a Subunit of the Mouse Vacuolar Proton-translocating ATPase* , 2000, The Journal of Biological Chemistry.

[8]  M. Zheng,et al.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. , 2000, The American journal of pathology.

[9]  H. Väänänen,et al.  The cell biology of osteoclast function. , 2000, Journal of cell science.

[10]  Yuqiong Liang,et al.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification , 1999, Nature Genetics.

[11]  S. Gagliardi,et al.  Chemistry and Structure—Activity Relationships of Bafilomycin A1, a Potent and Selective Inhibitor of the Vacuolar H+‐ATPase , 2000 .

[12]  C. Löwik,et al.  Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro. , 1999, Journal of cell science.

[13]  M Forgac,et al.  Structure and Properties of the Vacuolar (H+)-ATPases* , 1999, The Journal of Biological Chemistry.

[14]  Farina,et al.  Selective inhibitors of the osteoclast vacuolar proton ATPase as novel bone antiresorptive agents. , 1999, Drug discovery today.

[15]  H. Väänänen,et al.  Decreased bone resorption, osteoclast differentiation, and expression of vacuolar H+-ATPase in antisense DNA-treated mouse metacarpal and calvaria cultures ex vivo. , 1999, Antisense & nucleic acid drug development.

[16]  S. Morony,et al.  Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Barrett,et al.  Reduced Capacitative Calcium Entry Correlates with Vesicle Accumulation and Apoptosis* , 1999, The Journal of Biological Chemistry.

[18]  L. Formigli,et al.  17β-Estradiol Induces Apoptosis in the Preosteoclastic FLG 29.1 Cell Line , 1999 .

[19]  E. Katchburian,et al.  Ultrastructural and lanthanum tracer examination of rapidly resorbing rat alveolar bone suggests that osteoclasts internalize dying bone cells , 1998, Cell and Tissue Research.

[20]  S. Gagliardi,et al.  Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase. , 1998, Journal of medicinal chemistry.

[21]  P. Nambi,et al.  5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity. , 1998, Journal of medicinal chemistry.

[22]  E. Lakatta,et al.  Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. , 1998, The Journal of clinical investigation.

[23]  M. Herslöf,et al.  Vacuolar H+‐ATPases Targets for Drug Discovery? , 1997, Annals of the New York Academy of Sciences.

[24]  S. Ralston,et al.  Cytokine‐Induced Nitric Oxide Inhibits Bone Resorption by Inducing Apoptosis of Osteoclast Progenitors and Suppressing Osteoclast Activity , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  A. Simpson,et al.  Biomaterial Particle Phagocytosis by Bone-Resorbing Osteoclasts , 1997 .

[26]  A. Simpson,et al.  Biomaterial particle phagocytosis by bone-resorbing osteoclasts. , 1997, The Journal of bone and joint surgery. British volume.

[27]  M. Kumegawa,et al.  Estrogen Inhibits Bone Resorption by Directly Inducing Apoptosis of the Bone-resorbing Osteoclasts , 1997, The Journal of experimental medicine.

[28]  H. Väänänen,et al.  Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. , 1997, Journal of cell science.

[29]  E. Jimi,et al.  Specific Inhibitors of Vacuolar H+‐ATPase Trigger Apoptotic Cell Death of Osteoclasts , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  A. Simpson,et al.  OSTEOCLASTS ARE CAPABLE OF PARTICLE PHAGOCYTOSIS AND BONE RESORPTION , 1997, The Journal of pathology.

[31]  M. Horton,et al.  Trafficking of matrix collagens through bone-resorbing osteoclasts. , 1997, Science.

[32]  P. Lehenkari,et al.  Removal of osteoclast bone resorption products by transcytosis. , 1997, Science.

[33]  Y. Minemoto,et al.  Bafilomycin A1 induces apoptosis in PC12 cells independently of intracellular pH , 1996, FEBS letters.

[34]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[35]  J. Lawry,et al.  Bisphosphonates induce apoptosis in mouse macrophage‐like cells in vitro by a nitric oxide‐independent mechanism , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  H. Geuze,et al.  Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump , 1995, The Journal of cell biology.

[37]  K. Sundquist,et al.  Bafilomycin A1 in bone resorption and tooth eruption in dogs. , 1995, European journal of oral sciences.

[38]  S. Krane,et al.  Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. , 1994, Endocrinology.

[39]  S. Marks,et al.  Bafilomycin A1 inhibits bone resorption and tooth eruption in vivo , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  J. Zhang,et al.  Proton conduction and bafilomycin binding by the V0 domain of the coated vesicle V-ATPase. , 1994, The Journal of biological chemistry.

[41]  H. Väänänen,et al.  Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. , 1994, The Journal of clinical investigation.

[42]  M. J. Clague,et al.  Vacuolar ATPase activity is required for endosomal carrier vesicle formation. , 1994, The Journal of biological chemistry.

[43]  R. Gillies,et al.  Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.

[44]  N. Nelson.  Structure and function of V-ATPases in endocytic and secretory organelles. , 1992, The Journal of experimental biology.

[45]  R. Baron,et al.  The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases. , 1992, The Journal of experimental biology.

[46]  I. Herman,et al.  Immunolocalization of the vacuolar-type (H+)-ATPase from clathrin-coated vesicles. , 1991, European journal of cell biology.

[47]  K. Väänänen,et al.  Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. , 1990, Biochemical and biophysical research communications.

[48]  S. Wysocki,et al.  Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand. , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  L. Formigli,et al.  17beta-estradiol induces apoptosis in the preosteoclastic FLG 29.1 cell line. , 1999, Biochemical and biophysical research communications.

[50]  T. Stevens,et al.  Structure, function and regulation of the vacuolar (H+)-ATPase. , 1997, Annual review of cell and developmental biology.

[51]  G. E. Dean,et al.  Resorption-cycle-dependent polarization of mRNAs for different subunits of V-ATPase in bone-resorbing osteoclasts. , 1996, Molecular biology of the cell.